05-Oct-16 Giving a push to local production of high-end medical equipment, the Indian government has given its nod to sub-lease over 300 acres of land in Chennai for the country's first medical devices manufacturing park. The project will reduce the dependence on imports and create a strong base for domestic industry by providing access to state-of-the-art infrastructure. [image: PTI]

GGM's 2016 China and Asia-Pacific Ophthalmology market intelligence program subscriptions are now available, giving you access to accurate market data, reliable buyer insights and private custom research topics. Covering Ophthalmology Equipment, IOLs and Hospital Services, the service includes country level data and analysis on: Market opportunities, competitive gaps, surgeon perceptions, installed base, usage, market volume and value size, prices, detailed segmentation, regulations and reimbursement, market players, future outlook, positioning recommendations and more. 

23-Sep-16 Philips, Macquarie University's MQ Health, and Emory Healthcare of the US have announced Australia's first remote intensive care unit (eICU) monitoring program, aimed to help high risk patients in need of 'round-the-clock' observation. "We aim to transform the delivery of care to address growing clinician shortages while improving patient outcomes," said Kevin Barrow, Managing Director of Philips Australia. [image: HIT Consultant]

30-Sep-16 German medtech firm Biotronik opened an expanded production plant in Singapore. The firm produces implantable pacemakers, defibrillators and stents. "This small nation of 5.5 mn people is the fourth-largest exporter of high-tech goods in the world... We will be manufacturing components for Biotronik's latest and most innovative products for distribution around the world," said Erik Trip, Managing Director. [image: Biotronik]

28-Sep-16 With the active ingredients in Traditional Chinese Medicine (TCM) now far better understood than ever before, a new range of hybrid TCM/Western treatments are wooing even the most cynical with their efficacy and lack of side-effects. Advances in research and development have enabled companies to integrate many of TCM's treatments and protocols with the latest technology and medical understanding. [image: HKTDC Research]